← Back to TTRX

Turn Therapeutics Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 11/05/2026Sep 2025Filed 13/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 11/05/2026Sep 2024Filed 13/11/2025
−$5.8−$1−$1.9−$1.2−$0.3−$0.7
−$0.20−$0.03−$0.07−$0.05−$0.01−$0.03
302928272727

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.